Regeneron Pharmaceuticals Inc

مادة اعلانية

Latest Update: 17 Sep 2024 23:59 Abu Dhabi Time.

Market Status: Closed

REGN

Regeneron Pharmaceuticals Inc

1,146.34

USD

-6.740

-0.58%

Open

1,151.10

Prev Close

1,153.08

PX_VOLUME

MARKET CAP (M)

116,468.28

DAY RANGE

1,134.60 - 1,151.10

52 WEEKS

688.52 - 1,081.17

Stock Statistics

Yearly Change

42.61%

Listed Shares (Million)

134.80

Earnings Multiple

30.53

Average 30-day trading volume

474,786.17

Price-to-book ratio

4.54

Earnings Per Share

37.05

Previous Dividend Distribution

Dividend Yield

0.00%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Total Revenue		3,547.10	3,145.00	3,434.30	3,362.70	3,158.10	3,162.10
Gross Profit		3,066.90	2,711.20	3,019.60	2,926.30	2,753.20	2,704.60
Operating Income		1,108.10	773.80	1,105.20	1,211.00	1,016.50	1,002.80
Profit Margin		40.38	22.96	33.77	29.97	30.66	25.86

	Period Ending:	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Revenue		13,117.20	12,172.90	16,071.70	8,497.10
Gross Profit		11,403.70	10,871.20	13,865.90	7,377.20
Operating Income		4,335.50	5,252.70	9,222.50	3,566.60
Profit Margin		30.14	35.64	50.25	41.35

Balance Sheet

	Period Ending:	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Total Assets		36,086.80	34,369.60	33,080.20	32,163.30	30,657.50	30,059.90
Total Liabilities		7,881.00	7,378.50	7,107.10	7,258.90	6,639.60	6,564.70
Total Equity		28,205.80	26,991.10	25,973.10	24,904.40	24,017.90	23,495.20

Cash Flows Statements - Coming Soon

* In Million of United States Dollar

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.

REGN

Regeneron Pharmaceuticals Inc

ريجينيرون فارماسوتيكالز